Characterization of spontaneous, In vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv.
about
Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspectiveAcquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency.Pre-existing isoniazid resistance, but not the genotype of Mycobacterium tuberculosis drives rifampicin resistance codon preference in vitroDNA alkylation damage as a sensor of nitrosative stress in Mycobacterium tuberculosisSystematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis.A rifampin-hypersensitive mutant reveals differences between strains of Mycobacterium smegmatis and presence of a novel transposon, IS1623.Different rifampin sensitivities of Escherichia coli and Mycobacterium tuberculosis RNA polymerases are not explained by the difference in the beta-subunit rifampin regions I and II.Role of the DinB homologs Rv1537 and Rv3056 in Mycobacterium tuberculosisEvolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patientEvaluation of the TB-Biochip oligonucleotide microarray system for rapid detection of rifampin resistance in Mycobacterium tuberculosis.Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.QSAR based therapeutic management of M. tuberculosis.Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalenceDNA repair in Mycobacterium tuberculosis revisited.Diverse drug-resistant subpopulations of Mycobacterium tuberculosis are sustained in continuous culture.Correlation of rpoB Mutations with Minimal Inhibitory Concentration of Rifampin and Rifabutin in Mycobacterium tuberculosis in an HIV/AIDS Endemic Setting, South Africa.Rapid detection of Mycobacterium tuberculosis and pyrazinamide susceptibility related to pncA mutations in sputum specimens through an integrated gene-to-protein function approachMoxifloxacin retains antimycobacterial activity in the presence of gyrA mutations.Resistance to rifampicin: a review.A genotypic approach for detection, identification, and characterization of drug resistance in Mycobacterium ulcerans in clinical samples and isolates from Ghana.New insights into the survival mechanisms of rifampicin-resistant Mycobacterium tuberculosis.Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations.Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis.Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants.Identification of Nudix hydrolase family members with an antimutator role in Mycobacterium tuberculosis and Mycobacterium smegmatis.Three nth homologs are all required for efficient repair of spontaneous DNA damage in Deinococcus radiodurans.Deregulation of Genes Associated with Alternate Drug Resistance Mechanisms in Mycobacterium tuberculosis.Molecular characterization of Rifr mutations in Enterococcus faecalis and Enterococcus faecium.RpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis strains isolated in the Aegean region of Turkey.
P2860
Q24535810-4540AFE1-B991-42CE-BF5C-FD9947AECC6FQ24814339-CAB58153-82A2-4BBF-B190-72EEAB7F1671Q28478663-E652DC77-210A-4C99-906A-E03810DA1879Q28486985-55716957-234B-49AE-A718-BF942638A53AQ30419570-EE952025-2C7E-454B-B863-9DE0165CF07AQ33193258-38944722-DD07-4ACA-B150-6756CB37E155Q33721974-4A63004E-3B41-4544-AC57-34FF83AAD253Q33769195-952CC5E0-7877-4B29-94C1-E97FF97DDCA4Q34466858-E8C76034-7C54-40B6-A3A9-1EE14A8D5316Q34719995-56FECC7D-5003-49EC-9D86-1A2C8D9F20C3Q34933405-9565422C-5DB9-4942-832B-5274650EBE39Q36094198-36E60883-0641-4A2E-A0F3-ECC4A99D566AQ36359056-43EA94B2-453B-44BD-9ACC-E2697B983013Q36539733-14915FC1-B9E9-4150-87DE-21975143D611Q37455209-471D0A5B-A994-4A08-892A-9EC9183F42B7Q37466064-74FE3F5B-C31F-4954-8C79-5A8E7EE4D144Q37471180-22A8C949-239D-486E-B35E-5FEA5768AA8CQ37546819-E0987763-F192-444F-B056-FD679C92578BQ37713049-7D54C762-70A2-4963-8D2F-C0E07F82B9F4Q38239459-19B014FF-F1F7-42D5-BF8C-DAC58B5CD202Q38900297-C7E1E409-7F05-43BC-8E6B-41A7DDD052D5Q38930894-2597AA21-0310-44FE-A2E2-C0DD7ECE5161Q39478765-D48854CA-2E79-4FB3-9FE9-7D64424B09BAQ40572948-E526E301-DF3C-4470-BF95-48C7C2EC733AQ42550095-8D570C48-4E43-4702-B50C-4ABD4E07CF9EQ42941702-A42D1E6B-7C50-4AAD-987F-C9AE589D2E84Q43015153-2971D622-0462-4CA7-A6C3-7D804FE05163Q47578348-CCADA65A-B75D-44ED-92FB-0380DAC8C9DDQ50769650-91E52F0E-BABA-4434-BBD5-FECC2BED092BQ53878786-026F6E0B-2B75-40B0-BD72-A75C56B52069
P2860
Characterization of spontaneous, In vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Characterization of spontaneou ...... ium tuberculosis strain H37Rv.
@ast
Characterization of spontaneou ...... ium tuberculosis strain H37Rv.
@en
type
label
Characterization of spontaneou ...... ium tuberculosis strain H37Rv.
@ast
Characterization of spontaneou ...... ium tuberculosis strain H37Rv.
@en
prefLabel
Characterization of spontaneou ...... ium tuberculosis strain H37Rv.
@ast
Characterization of spontaneou ...... ium tuberculosis strain H37Rv.
@en
P2093
P2860
P1476
Characterization of spontaneou ...... ium tuberculosis strain H37Rv.
@en
P2093
B B Plikaytis
G P Morlock
J T Crawford
P2860
P304
P356
10.1128/AAC.44.12.3298-3301.2000
P407
P577
2000-12-01T00:00:00Z